EarningsQ2 2026 Earnings Report
MX:MED Q2 2026 EPS Results
Actual EPS-$5.08
Consensus EPS-$11.80
Beat/MissBeat by +$6.72
One Year Ago EPS$7.28
MX:MED Q2 2026 Revenue Results
Actual Revenue$1.39B
Expected Revenue$1.32B
Beat/MissBeat by +$66.90M
YoY Revenue Growth-27.64%
Earnings Announcement Details
QuarterQ2 2026
Date08/03/2026
TimeAfter Close
Conference CallMonday, August 3, 2026
MX:MED Upcoming Earnings
Medifast's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:MED Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presented a mixed picture: materially negative near-term operating and top-line trends (notably a 27.6% revenue decline and a 48.7% drop in active coaches) contrast with strong strategic initiatives, improving coach productivity (+41% YoY), a healthy balance sheet ($169.8M cash, no debt), and targeted cost actions (Catalyst) with a goal to return to profitability in Q4 2026. Management emphasized structural steps (new Trilivy brand, scientific institute, compensation changes and training) that could drive medium-term recovery, but sizable current financial pressures and near-term uncertainty remain.Company Guidance
Revenue In Line with Guidance
Second quarter revenue of $76.4 million, in line with the company’s guidance and consistent with sequential stabilization seen since late 2025.
Substantial Coach Productivity Gains
Average revenue per active earning coach was $6,529, up 41.0% year-over-year and up ~20% sequentially versus Q1; revenue per active earning coach is the highest since Q2 2022.
New Strategic Brand and Product Launch
Launched Trilivy as the primary consumer brand and a new MetaVantage Technology Reset product line (Reset Fuelings) with overwhelmingly positive pilot feedback; public rollout planned in the quarter.
Investment in Science and Credibility
Launched the Medifast Metabolic Health Institute to advance research, product development, and evidence-based communications to strengthen scientific differentiation and commercial positioning.
Field Engagement and Training
High coach engagement (sold-out coach convention), rollout of Trilivy Coach Hub training, and an enhanced coach compensation plan (launched Aug 1) designed to accelerate development of high-producing Executive Directors; percentage of active earning coaches at Executive Director rank remains above the 10% benchmark.
Strong Liquidity and Balance Sheet
Ended the quarter with $169.8 million in cash, cash equivalents, and investments and no debt; working capital support and an enterprise value below cash/investments noted as a financial strength.
Cost Reduction Progress
SG&A declined 25.7% year-over-year to $57.7 million, driven by a $12.6 million decrease in coach compensation, $2.3 million lower salary/benefit expense, and $2.0 million lower company-led marketing spend.
Catalyst Program and Profitability Target
Launched the Catalyst cost-savings program (facility rationalization, AI efficiencies, etc.) and reiterated target to return to profitability in Q4 2026, with additional details and quantified savings to be provided in Q3.
MX:MED Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed